Medical Tests

Explore lab tests, blood work, and imaging exams with plain-language preparation and overview pages.

Featured: 100

Browse Directory Sections

Browse A-Z

Page 2 of 25

Tests starting with O (2,433)

Other

OASIS E - Mobility - SOC and ROC performance during assessment period [CMS Assessment]

Other

OASIS E - Mobility - discharge performance during assessment period [CMS Assessment]

Other

OASIS E - Mobility - follow-up performance during assessment period [CMS Assessment]

Other

OASIS E - Other diagnoses during assessment period [CMS Assessment]

Other

OASIS E - Participation in Assessment and Goal Setting - TRN, DC during assessment period [CMS Assessment]

Other

OASIS E - Preferences for Customary Routine Activities - DC during assessment period [CMS Assessment]

Other

OASIS E - Preferences for Customary Routine Activities - SOC, ROC during assessment period [CMS Assessment]

Other

OASIS E - Primary diagnosis during assessment period [CMS Assessment]

Other

OASIS E - Self-care - SOC and ROC performance during assessment period [CMS Assessment]

Other

OASIS E - Self-care - discharge performance during assessment period [CMS Assessment]

Other

OASIS E - Self-care - follow-up performance during assessment period [CMS Assessment]

Other

OASIS E - Skin Conditions - DC during assessment period [CMS Assessment]

Other

OASIS E - Skin Conditions - FU during assessment period [CMS Assessment]

Other

OASIS E - Skin Conditions - SOC, ROC during assessment period [CMS Assessment]

Other

OASIS E - Special Treatment, Procedures, and Programs - ROC during assessment period [CMS Assessment]

Other

OASIS E - Special Treatment, Procedures, and Programs - SOC during assessment period [CMS Assessment]

Other

OASIS E - Special Treatment, Procedures, and Programs - discharge from agency during assessment period [CMS Assessment]

Other

OASIS E - Special Treatment, Procedures, and Programs - transfer to an inpatient facility during assessment period [CMS Assessment]

Other

OASIS E - Swallowing And Or Nutritional Status - DC during assessment period [CMS Assessment]

Other

OASIS E - Swallowing And Or Nutritional Status - ROC during assessment period [CMS Assessment]

Other

OASIS E - Swallowing And Or Nutritional Status - SOC during assessment period [CMS Assessment]

Other

OASIS E2 - DC during assessment period [CMS Assessment]

Other

OASIS E2 - TRN during assessment period [CMS Assessment]

Imaging

OB ultrasound imaging device Class

Imaging

OB ultrasound imaging device Institution inventory number

Imaging

OB ultrasound imaging device Vendor model number

Imaging

OB ultrasound imaging device Vendor serial number

Other

OB ultrasound panel

Blood test

OCA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

Blood test

OCRL1 mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

Other

OCT2 Ag [Presence] in Tissue by Immune stain

Blood test

OJ Ab [Measurement] in Serum

Blood test

OJ Ab [Presence] in Serum

Blood test

OJ Ab [Presence] in Serum by Immunoblot

Blood test

OJ Ab [Presence] in Serum by Radioimmunoprecipitation assay (RIPA)

Blood test

OJ Ab [Units/volume] in Serum

Blood test

OJ Ab [Units/volume] in Serum by Line blot

Blood test

OJ IgG Ab [Presence] in Serum by Line blot

Blood test

OKT3 [Mass/volume] in Serum or Plasma

Blood test

OKT3 blocking Ab [Titer] in Serum or Plasma by Flow cytometry (FC)

Other

OLANZapine [Mass/mass] in Tissue

Blood test

OLANZapine [Mass/volume] in Blood

Other

OLANZapine [Mass/volume] in Body fluid

Blood test

OLANZapine [Mass/volume] in Serum or Plasma

Other

OLANZapine [Mass/volume] in Urine

Other

OLANZapine [Mass/volume] in Urine by Confirmatory method

Other

OLANZapine [Mass] of Dose

Blood test

OLANZapine [Measurement] in Serum or Plasma

Other

OLANZapine [Measurement] in Urine

Other

OLANZapine [Moles/volume] in Gastric fluid

Blood test

OLANZapine [Moles/volume] in Serum or Plasma

Other

OLANZapine [Moles/volume] in Specimen

Other

OLANZapine [Moles/volume] in Urine

Blood test

OLANZapine [Presence] in Serum or Plasma by Screen method

Other

OLANZapine [Presence] in Urine

Other

OLANZapine cutoff [Mass/volume] in Urine for Confirmatory method

Blood test

OLANZapine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)

Blood test

OLANZapine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)

Blood test

OLANZapine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)

Blood test

OLANZapine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)

Blood test

OLANZapine panel - Serum or Plasma

Blood test

OPA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method

Blood test

OPA3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method

Other

OPC3373 (Metabolite of Ariprazole) [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine

Other

OPC3373 (Metabolite of Ariprazole) [Mass/volume] in Urine by Confirmatory method

Other

OPC3373 (Metabolite of Ariprazole) [Z-score] in Urine

Other

OPC3373 (Metabolite of Ariprazole) cutoff [Mass/volume] in Urine for Confirmatory method

Blood test

OPRM1 gene c.118A>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal

Other

OPTIMAL change scores - confidence

Other

OPTIMAL change scores - difficulty

Other

OPTIMAL confidence - baseline

Other

OPTIMAL confidence - follow up

Other

OPTIMAL difficulty - baseline

Other

OPTIMAL difficulty - follow up

Blood test

OTC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

Blood test

OTC gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

Blood test

OTC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method

Blood test

OTOF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method

Other

OXA-23 carbapenemase [Presence] by Rapid immunoassay

Other

OXA-40 and OXA-58 carbapenemase [Presence] by Rapid immunoassay

Other

OXA-48-like carbapenemase [Presence] in Isolate by Rapid immunoassay

Blood test

OXcarbazepine + 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

Blood test

OXcarbazepine [Mass/volume] in Serum or Plasma

Blood test

OXcarbazepine [Mass/volume] in Serum or Plasma --trough

Other

OXcarbazepine [Mass/volume] in Urine by Confirmatory method

Other

OXcarbazepine [Measurement] in Urine

Other

OXcarbazepine [Moles/volume] in Gastric fluid

Blood test

OXcarbazepine [Moles/volume] in Serum or Plasma

Blood test

OXcarbazepine [Moles/volume] in Serum or Plasma --trough

Other

OXcarbazepine [Moles/volume] in Specimen

Other

OXcarbazepine [Moles/volume] in Urine

Other

OXcarbazepine [Presence] in Urine by Confirmatory method

Blood test

OXcarbazepine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)

Blood test

OXcarbazepine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)

Blood test

OXcarbazepine trough and 10-hydroxycarbazepine panel - Serum or Plasma

Blood test

Oak wood dust IgE Ab [Units/volume] in Serum

Blood test

Oat IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)

Blood test

Oat IgE Ab [Units/volume] in Serum

Blood test

Oat IgE Ab [Units/volume] in Serum or Plasma by Immunoassay

Blood test

Oat IgE Ab/IgE total in Serum

Frequently Asked Questions

The directory currently focuses public pages on blood tests and imaging exams. Other imported test records remain draft data until templates and quality checks are ready.